Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein

The recent outbreak of Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) infection has led to more than 800 laboratory-confirmed MERS cases with a high case fatality rate (∼35%), posing a serious threat to global public health and calling for the development of effective and safe therap...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Virus Res
Main Authors: Xia, Shuai, Liu, Qi, Wang, Qian, Sun, Zhiwu, Su, Shan, Du, Lanying, Ying, Tianlei, Lu, Lu, Jiang, Shibo
Format: Artigo
Jezik:Inglês
Izdano: Elsevier B.V. 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114414/
https://ncbi.nlm.nih.gov/pubmed/25451066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virusres.2014.10.007
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki